Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Overview of topics
- Molecular & cellular events in skin wound healing
- Controlled wound inflammation is beneficial
- A common pathology of chronic wounds?
- Hypothesis of chronic wound pathophysiology
- Basic background of bacterial biofilms
- Biofilm development
- Biofilms made easy
- How response to biofilms causes tissue damage
- High levels of MMP activity in chronic wounds
- Protease activity predicts rate & extent of healing
- MMP-9 activity correlates with wound healing
- Fibronectin in wounds and ulcers
- MMPs made easy
- Biofilms in biopsies of chronic & acute wounds
- Does formation of biofilm retard healing?
- Biofilm formation delays healing in mouse
- Why are bacteria in biofilms hard to kill?
- Reaction-diffusion problem
- Biofilms are highly tolerant to antibiotics
- Topical antibiotics: planktonic vs. biofilm bacteria
- Thicker biofilm requirements concerning antibiotics
- Metabolic activity of Pseudomonas aeruginosa
- Dissolved oxygen gradients measured in biofilm
- Aerotolerance of bacteria in chronic wounds
- Biofilm based wound care
- Principles of biofilm based wound care
- Extending the 'TIME' concept
- What is the wound slough?
- Forming biofilms in wounds after debridement
- Sharp debridement opens a therapeutic window
- Debridement - biofilm will reform
- Do all wound dressings effectively kill biofilm?
- Can dressings disrupt & kill mature biofilms?
- 24 hr continuous exposure of mature biofilm
- Antimicrobial dressing efficacy against biofilm
- Larval debridement therapy
- What effect does NPWT have on killing biofilm?
- Assessment of NPWT + instillation on biofilms
- Effects of NPWT-instillation treatments (24 hours)
- Summary of NPWT + instillation on biofilms
- Summary
Topics Covered
- Sequence of Molecular and Cellular Events in Skin Wound Healing
- Hypothesis of Chronic Wound Pathophysiology
- Bacterial Biofilms
- Damage caused by immune response to biofilms
- Role of matrix metalloproteinases in wound healing
- Why are biofilms difficult to kill?
- Can Dressings Disrupt & Kill Mature Biofilms?
- Larval Debridement Therapy
- Negative Pressure Wound Therapy
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Schultz, G. (2022, October 11). Biofilms and chronic wounds: winning the war in wounds [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/WJYU4117.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Gregory Schultz, Consultant: Hollister Wounder Care, Medline, Acelity; Grant/Research Support (Principal Investigator): Hollister Wound Care, Medline, Acelity, Smith & Nephew; Stock Shareholder (Self-managed): QuickMed Technologies, BioMonde
A selection of talks on Dermatology
Transcript
Please wait while the transcript is being prepared...
0:00
Hello.
My name is Gregory Schultz, and
I'm a Professor of Obstetrics
and Gynecology, and Director
of the Institute for Wound
Research at the
University of Florida.
This presentation will focus on
the important topic of biofilms
and chronic wounds, and especially
how to win the war in wounds.
0:21
As an overview of topics, we're
going to briefly review the four
sequential phases of
normal wound healing,
because we want to specifically
recognize the beneficial effects
of controlled inflammation
and protease activities.
Because we want to understand
there is a very strong link
between chronic inflammation that is
caused by both planktonic or single
bacteria, as well as bacteria when
they're in this biofilm community
that we're going to talk about.
Because these bacteria are
extremely inflammatory,
and they cause elevated
levels of protease activities
that destroy proteins that
are essential for healing,
such as the extracellular
matrix proteins,
growth factors, and their receptors.
A key point about understanding the
difference between bacteria growing
as single planktonic
and biofilm communities
is that biofilm bacteria are
highly tolerant to most antibiotics,
antiseptics and
disinfectants that are
able to kill planktonic
bacteria very rapidly.
In addition, we want to try to
integrate these ideas and concepts
about the molecular biology
of bacteria in biofilms
into the integrated concept
of biofilm based wound care.
And the good news is
that this is really
just a slight different emphasis
in the concept of wound bed
preparation-- or the TIME
acronym-- because it emphasizes
the critical importance
of debriding biofilms,
and then especially
preventing the bacteria
in planktonic form from
reforming the biofilm rapidly.